Acarix AB (DE:7AC)
FRANKFURT:7AC
Germany Market
Holding DE:7AC?
Track your performance easily

Acarix AB (7AC) Stock Price & Analysis

1 Followers

7AC Stock Chart & Stats


Financials

Annual

7AC FAQ

What was Acarix AB’s price range in the past 12 months?
Acarix AB lowest stock price was €0.01 and its highest was €0.05 in the past 12 months.
    What is Acarix AB’s market cap?
    Currently, no data Available
    When is Acarix AB’s upcoming earnings report date?
    Acarix AB’s upcoming earnings report date is Nov 07, 2024 which is in 74 days.
      How were Acarix AB’s earnings last quarter?
      Acarix AB released its earnings results on Aug 22, 2024. The company reported -€0.002 earnings per share for the quarter, missing the consensus estimate of €0 by -€0.002.
        Is Acarix AB overvalued?
        According to Wall Street analysts Acarix AB’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Acarix AB pay dividends?
          Acarix AB does not currently pay dividends.
          What is Acarix AB’s EPS estimate?
          Acarix AB’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Acarix AB have?
          Acarix AB has 973,170,170 shares outstanding.
            What happened to Acarix AB’s price movement after its last earnings report?
            Acarix AB reported an EPS of -€0.002 in its last earnings report, missing expectations of €0. Following the earnings report the stock price went down -33.333%.
              Which hedge fund is a major shareholder of Acarix AB?
              Currently, no hedge funds are holding shares in DE:7AC
              ---

              Acarix AB Stock Smart Score

              Company Description

              Acarix AB

              Acarix AB operates as a medical technology company which is engaged in developing diagnostic tests for cardiovascular diseases primarily in Europe, China, and the United States. Its main activities are to develop, produce and market a new cardiovascular diagnostic method and similar equipment for the same and related services. The company develops the CADScor acoustic device that is designed to be used by doctors to help assess patients' risk of coronary artery disease.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              FinLab AG
              Popular Stocks
              ---
              What am I Missing?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis